Catherine Gagnon
Geen lopende functies
Profiel
Catherine Gagnon is currently a Director at Katana Biopharma, Inc. She was previously a Director at Ovensa, Inc. and Head of Business Development at Angiochem, Inc. She received a graduate degree from the University of Montréal in 2000.
Eerdere bekende functies van Catherine Gagnon
Bedrijven | Functie | Einde |
---|---|---|
Katana Biopharma, Inc.
Katana Biopharma, Inc. Hospital/Nursing ManagementHealth Services Katana Biopharma, Inc. operates oncology related technology platform. It develops a proprietary technology platform using peptides as a vehicle to specifically deliver existing cytotoxic agents to sortilin receptors, which are overexpressed on cancer cells. The company was founded by Richard Béliveau and Borhane Annabi in 2016 is headquartered in Montréal, Canada. | Directeur/Bestuurslid | - |
Ovensa, Inc.
Ovensa, Inc. Internet Software/ServicesTechnology Services Ovensa, Inc. operates as a preclinical stage biotechnology company. It focuses in oncology and neurodegenerative diseases. The company is headquartered in Aurora, Canada. | Directeur/Bestuurslid | - |
Angiochem, Inc.
Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | - |
Opleiding van Catherine Gagnon
University of Montréal | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Angiochem, Inc.
Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Health Technology |
Ovensa, Inc.
Ovensa, Inc. Internet Software/ServicesTechnology Services Ovensa, Inc. operates as a preclinical stage biotechnology company. It focuses in oncology and neurodegenerative diseases. The company is headquartered in Aurora, Canada. | Technology Services |
Katana Biopharma, Inc.
Katana Biopharma, Inc. Hospital/Nursing ManagementHealth Services Katana Biopharma, Inc. operates oncology related technology platform. It develops a proprietary technology platform using peptides as a vehicle to specifically deliver existing cytotoxic agents to sortilin receptors, which are overexpressed on cancer cells. The company was founded by Richard Béliveau and Borhane Annabi in 2016 is headquartered in Montréal, Canada. | Health Services |